Enhertu notched another win for AstraZeneca and Daiichi Sankyo that could see uptake moved slightly earlier in a specific ...
Lung cancer is the world’s leading cause of death due to cancer according to the World Health Organization.1 Thus an urgent ...
Flagship-incubated Repertoire Immune Medicines has lined up an autoimmune disease pact with Bristol Myers Squibb, marking the ...
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add ...
It was a positive week for the European Medicines Agency’s human medicines committee (CHMP), which recommended the approval ...
The FDA on Friday approved a label update on Biktarvy, Gilead’s blockbuster HIV drug, to include more data on the drug’s safety and efficacy for pregnant people with HIV. The additional data reflected ...
Sen. Bernie Sanders (I-VT) is calling on global pharmaceutical leaders to get behind proposals laid out in a World Health ...
Ipsen’s new sponsored TikTok features the popular “Of course” trend and two social influencers, but with a rare disease twist ...
AbbVie's effort to protect Humira's market share is getting expensive. On Friday, the company announced a 40% decline in the ...
We’re in a frothy time,” acknowledges Alexandra Snyder, the head of R&D at Generate:Biomedicines. Generate is one of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results